Tag: Rare Disease

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than...

Read More

Gaucher disease Market: Pipeline and Future Trends

Articles

Gaucher Disease Market is anticipated to enhance in the forecast period owing to a strong Gaucher disease pipeline. According to the...

Read More

Cost ineffective Orphan Drugs limit the access

Business Consultant, DelveInsight's Drug Report, Orphan market, Pharma Consultant

Rare diseases are mostly serious, chronic and life-threatening, associated with both psychological as well as financial burdens. In...

Read More

Wiskott – Aldrich syndrome – a rare X-linked disorder

Articles, Business Consultant, Pharma Consultant

Wiskott – Aldrich syndrome (also known as WAS) is a rare X-linked recessive genetic disorder that affects both T-lymphocytes and...

Read More

Anterior Uveitis market

Articles

Uveitis is a set of conditions defined by intraocular inflammation and is believed to be the cause of up to 10% of legal blindness in the...

Read More
Close